Novel de novo pathogenic variant in the GNAI1 gene as a cause of severe disorders of intellectual development

被引:2
|
作者
Wayhelova, Marketa [1 ,2 ,6 ]
Vallova, Vladimira [1 ,2 ]
Broz, Petr [1 ,3 ,4 ]
Mikulasova, Aneta [5 ]
Loubalova, Dominika [1 ]
Filkova, Hana [2 ]
Smetana, Jan [1 ]
Drabova, Klara [6 ]
Gaillyova, Renata [6 ]
Kuglik, Petr [1 ,2 ]
机构
[1] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno, Czech Republic
[2] Univ Hosp Brno, Ctr Mol Biol & Genet, Dept Internal Med Haematol & Oncol, Lab Cytogen, Brno, Czech Republic
[3] Charles Univ Prague, Fac Med 2, Dept Biol & Med Genet, Brno, Czech Republic
[4] Fac Hosp Moto, Brno, Czech Republic
[5] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England
[6] Univ Hosp Brno, Dept Med Genet & Genom, Brno, Czech Republic
关键词
MUTATIONS;
D O I
10.1038/s10038-021-00988-w
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Pathogenic sequence variant in the GNAI1 gene were recently introduced as a cause of novel syndrome with a manifestation of variable developmental delay and autistic features. In our study, we report a case of monozygotic twins with severe intellectual disability and motor delay and developmental dysphasia. Both probands and their parents were examined using multi-step molecular diagnostic algorithm including whole-exome sequencing (WES), resulting in the identification of a novel, de novo pathogenic sequence variant in the GNAI1 gene, NM_002069.6:c.815 A>G, p.(Asp272Gly) in probands. Using WES we also verified the microarray findings of a familial 8q24.23q24.3 duplication and heterozygous 5q13.2 deletion, not associated with clinical symptoms in probands. Our results confirmed the role of the GNAI1 gene in the pathogenesis of syndromic neurodevelopmental disorders. They support trio- or quatro-based WES as a suitable molecular diagnostics method for the simultaneous detection of clinically relevant sequence variants and CNVs in individuals with neurodevelopmental disorders and rare diseases.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 50 条
  • [41] De Novo Variants in TAOK1 Cause Neurodevelopmental Disorders
    Dulovic-Mahlow, Marija
    Trinh, Joanne
    Kandaswamy, Krishna Kumar
    Braathen, Geir Julius
    Di Donato, Nataliya
    Rahikkala, Elisa
    Beblo, Skadi
    Werber, Martin
    Krajka, Victor
    Busk, Oyvind L.
    Baumann, Hauke
    Al-Sannaa, Nouriya Abbas
    Hinrichs, Frauke
    Affan, Rabea
    Navot, Nir
    Al Balwi, Mohammed A.
    Oprea, Gabriela
    Holla, Oystein L.
    Weiss, Maximilian E. R.
    Jamra, Rami A.
    Kahlert, Anne-Karin
    Kishore, Shivendra
    Tveten, Kristian
    Vos, Melissa
    Rolfs, Arndt
    Lohmann, Katja
    AMERICAN JOURNAL OF HUMAN GENETICS, 2019, 105 (01) : 213 - 220
  • [42] De Novo Pathogenic Variant in FBRSL1, Non OMIM Gene Paralogue AUTS2, Causes a Novel Recognizable Syndromic Manifestation with Intellectual Disability; An Additional Patient and Review of the Literature
    Bukvic, Nenad
    De Rinaldis, Marta
    Chetta, Massimiliano
    Trabacca, Antonio
    Bassi, Maria Teresa
    Marsano, Rene Massimiliano
    Holoubkova, Lenka
    Rivieccio, Maria
    Oro, Maria
    Resta, Nicoletta
    Kerkhof, Jennifer
    Sadikovic, Bekim
    Viggiano, Luigi
    GENES, 2024, 15 (07)
  • [43] A novel de novo heterozygous pathogenic variant in the SDHA gene results in childhood onset bilateral optic atrophy and cognitive impairment
    Zehavi, Yoav
    Saada, Ann
    Jabaly-Habib, Haneen
    Dessau, Moshe
    Shaag, Avraham
    Elpeleg, Orly
    Spiegel, Ronen
    METABOLIC BRAIN DISEASE, 2021, 36 (04) : 581 - 588
  • [44] Renal and extra-renal phenotypes in a fetus with a de novo pathogenic variant in the HNF1B gene
    Tse, Wing Ting
    Cao, Ye
    Lam, Pensi Ping Hei
    Law, Kwok Ming
    Choy, Kwong Wai
    Ting, Yuen Ha
    PRENATAL DIAGNOSIS, 2024, 44 (02) : 251 - 254
  • [45] A novel de novo heterozygous pathogenic variant in the SDHA gene results in childhood onset bilateral optic atrophy and cognitive impairment
    Yoav Zehavi
    Ann Saada
    Haneen Jabaly-Habib
    Moshe Dessau
    Avraham Shaag
    Orly Elpeleg
    Ronen Spiegel
    Metabolic Brain Disease, 2021, 36 : 581 - 588
  • [46] Implications of a De Novo Variant in the SOX12 Gene in a Patient with Generalized Epilepsy, Intellectual Disability, and Childhood Emotional Behavioral Disorders
    Treccarichi, Simone
    Cali, Francesco
    Vinci, Mirella
    Ragalmuto, Alda
    Musumeci, Antonino
    Federico, Concetta
    Costanza, Carola
    Bottitta, Maria
    Greco, Donatella
    Saccone, Salvatore
    Elia, Maurizio
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (07) : 6407 - 6422
  • [47] Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability
    Sepide Dashti
    Shadab Salehpour
    Mohammad-Reza Ghasemi
    Hossein Sadeghi
    Masoumeh Rostami
    Farzad Hashemi-Gorji
    Reza Mirfakhraie
    Vahid Reza Yassaee
    Mohammad Miryounesi
    Neurological Sciences, 2022, 43 : 2859 - 2863
  • [48] A novel de novo frameshift variant in the CHD2 gene related to intellectual and developmental disability, seizures and speech problems
    Mir, Atefeh
    Song, Yongjun
    Lee, Hane
    Nadeali, Zakiye
    Tabatabaiefar, Mohammad Amin
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2024, 12 (01):
  • [49] Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability
    Dashti, Sepide
    Salehpour, Shadab
    Ghasemi, Mohammad-Reza
    Sadeghi, Hossein
    Rostami, Masoumeh
    Hashemi-Gorji, Farzad
    Mirfakhraie, Reza
    Yassaee, Vahid Reza
    Miryounesi, Mohammad
    NEUROLOGICAL SCIENCES, 2022, 43 (04) : 2859 - 2863
  • [50] Molecular and phenotypical findings of a novel de novo SYNGAP1 gene variant in an 11-year-old Iranian boy with intellectual disability
    Mir, Atefeh
    Song, Yongjun
    Lee, Hane
    Nadeali, Zakiye
    Akbarian, Fahimeh
    Tabatabaiefar, Mohammad Amin
    LABORATORY MEDICINE, 2024, 55 (02) : 204 - 208